Cannabis has been used to treat convulsions and other disorders since ancient times. In the
last few decades, preclinical animal studies and clinical investigations have established the …

Traditionally, selected plant sources have been explored for medicines to treat convulsions.
This continues today, especially in countries with low-income rates and poor medical …

Autism Spectrum Disorders (ASD) may significantly impact the well-being of patients and
their families. The therapeutic use of cannabis for ASD has gained interest due to its …

We evaluated the effects of cannabidiol (CBD) on seizures and peroxisome proliferator-
activated receptor gamma (PPARγ) levels in an animal model of temporal lobe epilepsy …

Neuropathic pain (NP) is a chronic disease that affects the normal quality of life of patients.
To date, the therapies available are only symptomatic and they are unable to reduce the …

Autism spectrum disorders and epilepsies are heterogeneous human disorders that have
miscellaneous etiologies and pathophysiology. There is considerable risk of frequent …

The scientific interest in Cannabis sativa L. analysis has been rapidly increasing in recent
years, especially for what concerns cannabinoids, plant secondary metabolites which are …

The use of Cannabis for medicinal purposes has been documented since ancient times,
where one of its principal cannabinoids extracted from Cannabis sativa, cannabidiol (CBD) …

There has been a significant increase in the consumption of cannabis for both recreational
and medicinal purposes in recent years, and its use can have long-term consequences on …

Scientific evidence exists about the association between neurological diseases (ie,
Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis (ALS), multiple …